Where Is Gilead Sciences Corporate Office Headquarters

Gilead Sciences Headquarters Address and Contact

Gilead Sciences logo
  • Address: 333 Lakeside Dr, Foster City, CA 94404, United States
  • Phone Number: +1 650-574-3000
  • Fax Number: (650) 578-9264
  • Email: corporate_development@gilead.com
  • Number of Employees: 11,000
  • Established: 1987
  • Founder: Michael L. Riordan
  • Key People: Daniel O’Day, Andrew Dickinson

Gilead Sciences Headquarters Location & Directions

How to Contact Gilead Sciences Corporate Office


Gilead Sciences Headquarters Info & Photos


{"autoplay":"true","autoplay_speed":3000,"speed":300,"arrows":"true","dots":"true"}

Gilead Sciences Headquarters List

  • List Element
  • List Element
  • List Element

Gilead Sciences Headquarters Executive Team

Daniel O’Day

Chairman and CEO

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Andrew Dickinson

Chief Financial Officer

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

William A. Lee, PhD

Executive Vice President, Research

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Name

Title

Jyoti Mehra

Executive Vice President, Human Resources

Johanna Mercier

Chief Commercial Officer

Merdad Parsey, MD, PhD

Chief Medical Officer

Brett A. Pletcher

Executive Vice President, Corporate Affairs and General Counsel

Christi Shaw

Chief Executive Officer, Kite

Taiyin Yang, PhD

Executive Vice President, Pharmaceutical Development and Manufacturing

About Gilead Sciences

History

Text

Services

Text

Facts

Text

Gilead Sciences Headquarters News

  • Kite Submits Biologics License Application to U.S. Food and Drug Administration for Company’s Second CAR T Cell Therapy
  • Kite and Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination of Yescarta® and Mavrilimumab in Relapsed or Refractory Large B-Cell Lymphoma
Rate This
>